Daegu, South Korea

Jeong Gyun Seo


Average Co-Inventor Count = 11.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jeong Gyun Seo: Innovator in Pharmaceutical Composition

Introduction

Jeong Gyun Seo is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in compositions aimed at treating serious health conditions. With a total of 2 patents, his work focuses on innovative solutions for cancer treatment and inflammatory diseases.

Latest Patents

Seo's latest patents include a composition for preventing or treating cancer. This invention provides a pharmaceutical composition that not only aims to inhibit tumor growth but also enhances immune functions and addresses cachexia caused by tumors. Additionally, it offers a synergistic effect when co-administered with existing anticancer drugs. Another significant patent involves methods for treating inflammatory diseases. This composition contains active ingredients that serve as an antitussive, expectorant, or anti-inflammatory agent. It is derived from natural materials, demonstrating minimal cytotoxicity, making it a safe option for medicinal or food compositions.

Career Highlights

Jeong Gyun Seo is associated with Okchundang Co., Ltd., where he continues to develop innovative pharmaceutical solutions. His work has garnered attention for its potential impact on public health, particularly in the treatment of cancer and respiratory diseases.

Collaborations

Seo collaborates with talented coworkers, including Sae Kwang Ku and Seong Min Ku. Their combined expertise contributes to the advancement of their projects and the overall mission of their company.

Conclusion

Jeong Gyun Seo stands out as an influential inventor in the pharmaceutical industry, with a focus on developing compositions that address critical health issues. His innovative patents reflect a commitment to improving treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…